Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations

B. Koopman, H.J.M. Groen, M.J.L. Ligtenberg, K. Grunberg, K. Monkhorst, A.J. de Langen, M.C. Boelens, M.S. Paats, J.H. von der Thusen, W.N.M. Dinjens, N. Solleveld, T. van Wezel, H. Gelderblom, L.E. Hendriks, E.J.M. Speel, T.E. Theunissen, L.I. Kroeze, N. Mehra, B. Piet, A.J. van der WekkenA. ter Elst, W. Timens, S.M. Willems, R.W.J. Meijers, W.W.J. de Leng, A.S.R. van Lindert, T. Radonic, S.M.S. Hashemi, D.A.M. Heideman, E. Schuuring, L.C. van Kempen

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)E1347-E1358
Number of pages12
JournalOncologist
Volume26
Issue number8
Early online date1 Jan 2020
DOIs
Publication statusPublished - Aug 2021

Keywords

  • cancer
  • decision making
  • genomics
  • molecular diagnostics
  • molecular tumor board
  • multidisciplinary
  • oncology
  • pathology
  • rare mutations
  • Rare mutations
  • Molecular diagnostics
  • Decision making
  • PATHOLOGY
  • CANCER
  • GENOMICS
  • ONCOLOGY
  • Molecular tumor board
  • Multidisciplinary

Cite this